Medlife invests in the development of the biggest private medical project in Romania: Medlife Medical Park

MedLife Medical System announced the acquisition of a land area of ​​9,500 square meters and of buildings with a built area of ​​5,000 square meters, while renting an adjacent land area of ​​2,500 square meters, respectively buildings of 2,000 square meters. The surfaces are adjacent to the MedLife Memorial hospital. The project will take place in 2 stages. In the first stage, MedLife Medical Park will have a total built area of ​​19,000 square meters that will be put into operation in the next 18-24 months. In the second phase, within 3-5 years, the company intends to build the MedLife Oncological Institute, following that the entire project, MedLife Medical Park, will reach a total built area of ​​approximately 50,000 square meters.

The first stage will last for 18-24 months and involves the development of a new hyperclinic and a state-of-the-art radiotherapy center that will come with some absolute news on the radiotherapy services market in Romania. At the same time, the MedLife Memorial hospital will be expanded and the In vitro Fertilization Center will be relocated and expanded.

Besides the medical operations, during the year 2021, the project will integrate a generous park, with green spaces and recreation areas for adults and children. In addition, two restaurants, a bio shop, as well as new parking spaces will be set up. "We live in an environment with a very high level of pollution and any initiative to reduce pollution, reduce useless consumption, conserve nature and grow the green areas around us is important. Beyond the health of our patients, we care about the quality of life of the communities we belong to, which is why our intention is to focus more, in the medium and long term, on this area, MedLife Medical Park becoming the largest medical project. green in Romania, strengthening our leadership position ”, said Mihai Marcu, President and CEO of MedLife.

Additionally, the company plans to open a medical research and training center. LifeScience will be the first private research center dedicated exclusively to training and innovation in medicine. It will include, besides the training and innovation center, spaces for students and young people who want to expose their innovative ideas in the medical field, respectively they want to start a business in the medical field or find partners and financing for medical start-ups. . The center will integrate a museum exhibition of Romanian medicine, photography and documents, the first equipment and tools for over 100 years, as well as a medical library. LifeScience will be able to host up to 300 people in conference rooms. The doctors, the university staff and the specialists in medical professional training will be able to present within the center the medical cases, the works and the innovations.

In the second stage, the company intends to develop from scratch a large center dedicated to the oncology area, the MedLife Oncological Institute. The unit will be arranged on a total surface of approx. 30,000 square meters and will include medical oncology, specialties related to the area of ​​oncology, chemotherapy and oncological surgery of excellence. The new unit is expected to be phased out over the next 3-5 years, with MedLife already undergoing a feasibility study to build the building.

"In Romania, a large-scale medical project model is missing, which includes powerful imaging, complex surgery, multidisciplinary medical teams and implicitly integrated services for the diagnosis and treatment of the most common pathologies. The project we are developing now is a first step in this regard. Basically, ten minutes from Piata Victoriei Romanians will have access to a clean air oasis and, at the same time, to one of the largest medical projects in Central and Eastern Europe with complex imaging, laboratory, hospitalization, but also integrated services. of oncology. It is a major project that marks the transition of MedLife to a new stage of development ”, said Mihai Marcu, CEO & President of the MedLife Medical System.

The first phase of the project will be financed mainly from own sources, coming from the company's cash flow. Currently, the feasibility study for the MedLife Oncological Institute is being worked on, following which the financing method, through credits, issuance of shares, bonds or a combination thereof, will be decided according to the discussions with the shareholders and the partner financial institutions.